Normalized growth velocity in children with Down's syndrome during growth hormone therapy
Authors:
- 1 August 1993
- journal article
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 37 (4) , 381-387
Abstract
Between 6 months and 3 years of age, growth velocity in children with Down's syndrome (DS) is markedly reduced in comparison to that of healthy children. However, after 3 years of age, it is almost normal. Thus, growth retardation becomes pronounced during the period when growth hormone (GH) starts to regulate growth. The present authors report the long‐term effects of GH‐therapy in 16 children with DS, who are being treated for 3 years from the age of 6–9 months. The treatment, Genotropin®, 0–1 U kg−1 BW day−1, was started at a mean age of7.4 (6.9) months. The results after 12 (n= 16), 24 (n= 12) and 30 (n = 8) months are presented. The mean height standard deviation score, SDS (range; Swedish standard), before therapy was ‐ 1.8 (−0.5 to −3.1) and the mean head circumference was −1.2 (−0.4 to −3.5). After 12, 24 and 30 months, the mean height SDS were −1.1 (−0.8 to −1.9), −0.9 (0 to −1.5) and −0.9 (0.1 to ‐ 1.5) and the mean head circumference SDS were −1.1 (0 to −2.5), ‐ M (0 to −2.2) and −1.2 (−0.5 to −2.0), respectively. During hGH‐treatment, the children with DS thus gained height during the first year, and then followed the growth rate of healthy Swedish children. When compared to growth charts for children with DS the mean height of these children started at the fiftieth centile and reached the ninety‐fifth centile after 24 months of treatment. Head circumference only slightly increased during the therapy, and not to the same extent as height. This indicates that small head circumference in DS is not only an effect of growth retardation, but also due to microcephaly.Keywords
This publication has 10 references indexed in Scilit:
- Treatment of children with Down syndrome and growth retardation with recombinant human growth hormoneThe Journal of Pediatrics, 1991
- Quality of Life Assessment Before and After Growth Hormone Treatment in Adults with Growth Hormone DeficiencyActa Paediatrica, 1989
- SIX WEEKS TO TWENTY‐ONE YEARS OLD: A LONGITUDINAL STUDY OF CHILDREN WITH DOWN'S SYNDROME AND THEIR FAMILIESJournal of Child Psychology and Psychiatry, 1988
- Growth Charts for Children With Down Syndrome: 1 Month to 18 Years of AgePediatrics, 1988
- Growth and somatomedin responses to growth hormone in Down's syndrome.Archives of Disease in Childhood, 1986
- The Presence of Normal Levels of Serum Immunoreactive Insulin-like Growth Factor 2 (IGF-2) in Patients with Down's SyndromeUpsala Journal of Medical Sciences, 1984
- Physical growth from birth to 16 years and longitudinal outcome of the study during the same age periodActa Paediatrica, 1976
- Plasma growth hormone in patients with chromosomal anomalies.Archives of Disease in Childhood, 1972
- Carbohydrate Tolerance, Growth Hormone and Insulin Levels in MongolismDevelopmental Medicine & Child Neurology, 1968
- RADIOGRAPHIC ATLAS OF SKELETAL DEVELOPMENT OF THE HAND AND WRISTThe American Journal of the Medical Sciences, 1959